Tempest Therapeutics director reports 2,000 TPST shares

Tempest Therapeutics director Richey William Drake reported ownership of 2,000 shares of Common Stock.

Rhea-AI Filing Summary

Tempest Therapeutics director Richey William Drake reported ownership of 2,000 shares of Common Stock. This Form 3 is an initial statement of beneficial ownership and does not show any recent buy or sell transaction, only that he directly holds these shares as of the reported date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Richey William Drake

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,000 shares (Direct)

Key Figures

Shares owned: 2,000 shares

1 metrics

Shares owned 2,000 shares Common Stock directly owned following the reported event

Key Terms

Form 3, beneficial ownership, Common Stock

3 terms

Form 3 regulatory

"This Form 3 is an initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"This Form 3 is an initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Common Stock financial

"He reports beneficial ownership of 2,000 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Tempest Therapeutics (TPST) director Richey William Drake report on this Form 3?

He reports beneficial ownership of 2,000 shares of Common Stock. The filing is an initial ownership statement and does not reflect any recent purchase or sale, only that he directly holds these shares as of the reported date.

Is there any buy or sell transaction disclosed for TPST in this Form 3?

No, the Form 3 for Tempest Therapeutics (TPST) does not show any buy or sell transactions. It simply records a holding entry indicating that director Richey William Drake directly owns 2,000 shares of Common Stock.

How many Tempest Therapeutics (TPST) shares does Richey William Drake directly own?

The Form 3 shows that he directly owns 2,000 shares of Tempest Therapeutics Common Stock. This reflects his beneficial ownership position following the reported event, with no change indicated from any recent insider trade in this filing.

Does this TPST Form 3 include any derivative securities for Richey William Drake?

No, this Form 3 lists only Common Stock holdings. The derivative section is empty, indicating no reported options, warrants, or other derivative securities for director Richey William Drake in this particular filing.

Is the 2,000-share TPST position held directly or indirectly by Richey William Drake?

The filing classifies the holding as direct ownership using ownership code “D.” There is no indication of indirect holdings through entities or family members in this Form 3, and no explanatory footnotes are provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 09:01 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Richey William Drake

(Last) (First) (Middle)

9 LUDLOW ST

(Street)

BOSTON MASSACHUSETTS 02129

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/04/2026

3. Issuer Name and Ticker or Trading Symbol
Tempest Therapeutics, Inc. [ TPST ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ William Drake Richey	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)